Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Self-reported Walking Impairment in Predominantly Illiterate Patients (WELSH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03482869
Recruitment Status : Unknown
Verified March 2018 by Nafi OUEDRAOGO, Université Polytechnique de Bobo-Dioulasso.
Recruitment status was:  Not yet recruiting
First Posted : March 29, 2018
Last Update Posted : March 29, 2018
Sponsor:
Information provided by (Responsible Party):
Nafi OUEDRAOGO, Université Polytechnique de Bobo-Dioulasso

Brief Summary:
The purpose of this study is to test the routine feasibility of an image tool adapted from the WELCH questionnaire ( Walking estimated limitation calculated by history) to estimate walking impairment (The WELSH questionnaire: Walking estimated limitation stated by history) in patients investigated for walking impairment. Secondary aims correlation with the maximal walking distance.

Condition or disease Intervention/treatment Phase
Diabetes Diagnostic Test: walking ability Not Applicable

Detailed Description:
The WELSH is self completed by the patients and scored by the physician after self-completion. Patients perform a 6 minutes walking test on a 30m corridor

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 150 participants
Intervention Model: Single Group Assignment
Intervention Model Description: Prospective cohort
Masking: None (Open Label)
Primary Purpose: Other
Official Title: The Walking Estimated Limitation Stated by History (WELSH): A Visual Tool to Self-report Walking Impairment From a Predominantly Illiterate Diabetic Population.
Estimated Study Start Date : March 30, 2018
Estimated Primary Completion Date : August 30, 2018
Estimated Study Completion Date : August 30, 2018

Arm Intervention/treatment
Experimental: Diabetic patients
Patients referred for the equilibrium or diagnosis of diabetes mellitus will be proposed to participate and estimate their walking ability with the WELSH (Walking estimated limitation stated by History) based solely on images
Diagnostic Test: walking ability
Included patients will perform a 6 min walk test




Primary Outcome Measures :
  1. Maximal walking distance [ Time Frame: 10 minutes ]
    Maximal measured distance will be the distance walked during a 6 min walk tests



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • •Signed consent for the data treatment as a database

Exclusion Criteria:

  • Rebuttal to participate

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03482869


Contacts
Layout table for location contacts
Contact: Nafi OUEDRAOGO, MD +22670155806 Nafioued@yahoo.fr

Locations
Layout table for location information
Burkina Faso
CHU Souro Sanou
Bobo Dioulasso, Burkina Faso
Contact: Nafi OUEDRAOGO         
Sponsors and Collaborators
Université Polytechnique de Bobo-Dioulasso
Investigators
Layout table for investigator information
Principal Investigator: Nafi OUEDRAOGO CHU Souro Sanou

Layout table for additonal information
Responsible Party: Nafi OUEDRAOGO, Head of department of physiology, Université Polytechnique de Bobo-Dioulasso
ClinicalTrials.gov Identifier: NCT03482869    
Other Study ID Numbers: Bobo 2018-001
First Posted: March 29, 2018    Key Record Dates
Last Update Posted: March 29, 2018
Last Verified: March 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Plan Description: Probably available upon request. Undecided yet

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Nafi OUEDRAOGO, Université Polytechnique de Bobo-Dioulasso:
walking impairment
disability
diabetes mellitus